Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Item

http://www.wikidata.org/entity/Q34579882

Q34579882

about

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma Curcumin AntiCancer Studies in Pancreatic Cancer Systemic Chemotherapy in Advanced Pancreatic Cancer Management of pancreatic cancer in the elderly Irreversible electroporation and the pancreas: What we know and where we are going?Albumin-bound paclitaxel in solid tumors: clinical development and future directions Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention Current advances in immunotherapy for pancreatic cancer Systemic treatment for inoperable pancreatic adenocarcinoma: review and update Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma Systemic therapies for pancreatic cancer--the role of pharmacogenetics Genetic factors affecting patient responses to pancreatic cancer treatment Advances in chemotherapy for pancreatic cancer Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone.Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity.A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial.Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.Gemcitabine Conjugated Chitosan and Double Antibodies (Abc-GC-Gemcitabine Nanoparticles) Enhanced Cytoplasmic Uptake of Gemcitabine and Inhibit Proliferation and Metastasis In Human SW1990 Pancreatic Cancer Cells.

P2860

Q24627664-61C25CFB-4E93-4E18-9862-376F5D50AB4D Q26738714-E232A79E-72CA-42F6-8502-49151698A4DE Q26750440-1D4BFD05-B031-440A-A993-FAFDB74D9E60 Q26774639-67E2409D-F847-4BD7-B520-2F0B86B9A15A Q26795522-18DB62F0-ABEC-473D-BD40-54448E33E846 Q26798674-1CE01487-FE12-4D78-9E57-B43841F0589E Q26801748-EEDECA2C-5C93-4DC3-88A8-F19FC417D4F3 Q26830170-D32C917B-B150-4E1D-A8CA-F553CD4D85F2 Q26830913-A94EE9D6-98C0-42E2-B8BC-CCB44AB22248 Q27012236-B335EA56-750E-4D62-989F-F1FC60A13F87 Q27021716-E134DE2C-098E-42B9-8E9D-1D57A1A68BC2 Q28075293-EFAEB838-B577-4C10-8B72-4605D4408209 Q28085711-B89CD30E-A906-4D87-9087-3163CE70436F Q28476694-801F4F92-5F4E-4B7F-BF13-4DF8A62B5425 Q28534413-0DFB1FD0-4A3B-4950-BC84-320CEEE4C489 Q30313606-3BFA514D-86E6-4423-8452-0F2B38F05DA0 Q30476261-1931EACB-5335-4152-B3BE-4E6553F499A5 Q33350085-0B62BFAB-FF91-496A-A137-E841CDA0C2EA Q33373308-9AE1A75C-6A25-4033-90A8-A074AD65A2AE Q33380084-84130E32-AFB3-4ABE-9A3E-E3E008C00C49 Q33382236-97534E14-BF86-4863-AAC0-FBEDF0CE6E91 Q33384793-BFA6FB69-80E2-43AD-BBB3-C2379F87BD25 Q33385864-296D5EBF-F47D-44FF-B55D-A88A4133BAAB Q33389637-05ADED38-90AC-4BE3-947C-FCFDC1772BA0 Q33394505-98F1E3D7-896C-4AA9-8BD8-1485B995B619 Q33394729-F16E42BC-F33C-43D7-B35A-E0584DEADDB7 Q33395047-9527F91C-0D2C-4856-A145-03632BFB3055 Q33395577-4586C5D1-BD09-4C7D-9E07-046CE064BF5E Q33396763-1ACBE1AB-53B4-4AC3-A1D0-E04EB7B27E9E Q33398693-9BDF622F-F221-4DC6-8EF8-4918A4B1F82A Q33402374-A15C6C99-679E-4298-8C87-5498236CB8F3 Q33403498-60FCEAF5-DC0F-46AD-82DD-FB6D44754C1F Q33412001-89726898-3095-40EC-9FE5-7E8CAFEF964A Q33416894-012750D4-25BA-471A-B76B-ED5A2E1F3138 Q33428016-72135373-669B-440B-AD30-602C292D7E7D Q33429920-C05150CA-3932-4BC8-BD5A-558D8C7C4F2A Q33432931-ACF2DEA3-D25D-4E9B-85E5-82A697CEBE8C Q33440500-F8E9A95E-2C9E-4AEB-A380-D1D4B83F2A8E Q33442676-0163C5D1-31BB-4C7C-B68C-6BB8F39881FB Q33553830-13B6168D-7174-4634-AFCA-6945E080B3CE

P2860

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Item

http://www.wikidata.org/entity/Q34579882

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu